CompletedNCT01887990
Intravenous Ketamine for Depression and Suicidal Thoughts
About this title
Read the official source — NCT01887990Medication studyAges 19+United StatesSuicide prevention
Understand this study
Who was this study for?
Listed age limits: from 19 years.
- Listed locations
- BirminghamSee all locations and recruitment
Study information
Study start dateStarted: May 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- Over 19 Years
- Official registry ID
- NCT01887990
- Official title
Show the full official title
Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alabama at Birmingham, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine and placebo.
Who was this study for?
Listed age limits: from 19 years.
